Categories News Press Releases Archives 2025 June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February May 23 UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be Presented at EULAR 2022 Read More Share:| | | May 12 Recognizing the Less Common, but Equally Burdensome, Forms of Arthritis During Arthritis Awareness Month Read More Share:| | | Jan 21 Positive Top-Line Results for bimekizumab in Second Phase 3 Psoriatic Arthritis Study Read More Share:| | | Nov 19 Positive Top-Line Results from Bimekizumab Phase 3 Psoriatic Arthritis Study Demonstrated Significant Improvements in Joint and Skin Symptoms Read More Share:| | | Pagination First page Previous page ‹ Previous Page 1 Current page 2